Description: Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.
Home Page: www.greencross.com
107, Ihyeon-ro 30beon-gil
Yongin-Si,
South Korea
Phone:
82 3 1260 9300
Officers
| Name | Title |
|---|---|
| Mr. Il-Sup Huh Ph.D. | Chairperson and Chief Exec. Officer |
| Dr. Eun Chul Huh | Pres |
| Mr. Yong-jun Hur | VP & Director |
| Mr. Man-Goo Yoo | Managing Director |
| Ms. Ae-Kyung Jang | Managing Director |
| Mr. Pyung-Ju Jang | Sr. Managing Director |
| Mr. Yong-Jun Huh | VP and Director |
Exchange: KO
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 60.241 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.7619 |
| Price-to-Sales TTM: | 0.3843 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 160 |